KCNJ14
geneOn this page
Also known as Kir2.4IRK4
Summary
KCNJ14 (potassium inwardly rectifying channel subfamily J member 14, HGNC:6260) is a protein-coding gene on chromosome 19q13.33, encoding ATP-sensitive inward rectifier potassium channel 14 (Q9UNX9). Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it.
Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel, and probably has a role in controlling the excitability of motor neurons.
Source: NCBI Gene 3770 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_013348
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:6260 |
| Approved symbol | KCNJ14 |
| Name | potassium inwardly rectifying channel subfamily J member 14 |
| Location | 19q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Kir2.4, IRK4 |
| Ensembl gene | ENSG00000182324 |
| Ensembl biotype | protein_coding |
| OMIM | 603953 |
| Entrez | 3770 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000342291, ENST00000391884
RefSeq mRNA: 1 — MANE Select: NM_013348
NM_013348
CCDS: CCDS12721
Canonical transcript exons
ENST00000342291 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001249475 | 48464181 | 48466980 |
| ENSE00001375684 | 48461670 | 48462438 |
| ENSE00001386307 | 48455574 | 48455858 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 69.53.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0189 / max 7.0574, expressed in 7 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176790 | 0.0189 | 7 |
Top tissues by expression
130 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 69.53 | gold quality |
| putamen | UBERON:0001874 | 68.72 | gold quality |
| stromal cell of endometrium | CL:0002255 | 65.82 | gold quality |
| gastrocnemius | UBERON:0001388 | 65.60 | gold quality |
| skin of leg | UBERON:0001511 | 64.70 | gold quality |
| primary visual cortex | UBERON:0002436 | 64.50 | gold quality |
| muscle of leg | UBERON:0001383 | 64.42 | gold quality |
| zone of skin | UBERON:0000014 | 64.24 | gold quality |
| ventricular zone | UBERON:0003053 | 64.11 | gold quality |
| skin of abdomen | UBERON:0001416 | 63.87 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 63.78 | gold quality |
| caudate nucleus | UBERON:0001873 | 63.72 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 62.41 | gold quality |
| prefrontal cortex | UBERON:0000451 | 62.06 | gold quality |
| frontal cortex | UBERON:0001870 | 61.61 | gold quality |
| cortical plate | UBERON:0005343 | 61.46 | gold quality |
| bone marrow | UBERON:0002371 | 61.32 | gold quality |
| right frontal lobe | UBERON:0002810 | 61.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 61.00 | gold quality |
| muscle tissue | UBERON:0002385 | 60.64 | gold quality |
| cerebellum | UBERON:0002037 | 60.34 | gold quality |
| esophagus mucosa | UBERON:0002469 | 60.26 | gold quality |
| bone marrow cell | CL:0002092 | 60.23 | gold quality |
| cerebellar cortex | UBERON:0002129 | 60.23 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 60.16 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 60.01 | gold quality |
| cerebral cortex | UBERON:0000956 | 59.97 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 59.83 | gold quality |
| brain | UBERON:0000955 | 59.54 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 59.09 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 34.64 |
| E-GEOD-137537 | yes | 16.68 |
| E-ANND-3 | yes | 3.54 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
63 targeting KCNJ14, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-4271 | 99.88 | 68.32 | 2244 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
Literature-anchored findings (GeneRIF, showing 4)
- Kir2.2 and Kir2.1 are primary determinants of endogenous K(+) conductance in HAECs under resting conditions and that Kir2.2 provides the dominant conductance in these cells. (PMID:15958527)
- Using patch-clamp techniques, we characterized K(IR) channels in cultured pulmonary artery smooth muscle cells and compared them to cloned Kir2.1 and Kir2.4 channels (PMID:17347781)
- KCNJ14 knockdown significantly inhibited the proliferation and migration of colorectal cells. (PMID:36100894)
- Comprehensive Analysis of KCNJ14 Potassium Channel as a Biomarker for Cancer Progression and Development. (PMID:36768373)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | kcnj14 | ENSDARG00000075914 |
| mus_musculus | Kcnj14 | ENSMUSG00000058743 |
| rattus_norvegicus | Kcnj14 | ENSRNOG00000021056 |
| rattus_norvegicus | Kcnj14 | ENSRNOG00000083583 |
Paralogs (15): KCNJ13 (ENSG00000115474), KCNJ5 (ENSG00000120457), KCNJ8 (ENSG00000121361), KCNJ2 (ENSG00000123700), KCNJ1 (ENSG00000151704), KCNJ16 (ENSG00000153822), KCNJ6 (ENSG00000157542), KCNJ15 (ENSG00000157551), KCNJ9 (ENSG00000162728), KCNJ3 (ENSG00000162989), KCNJ4 (ENSG00000168135), KCNJ10 (ENSG00000177807), KCNJ12 (ENSG00000184185), KCNJ11 (ENSG00000187486), KCNJ18 (ENSG00000260458)
Protein
Protein identifiers
ATP-sensitive inward rectifier potassium channel 14 — Q9UNX9 (reviewed: Q9UNX9)
Alternative names: Inward rectifier K(+) channel Kir2.4, Potassium channel, inwardly rectifying subfamily J member 14
All UniProt accessions (1): Q9UNX9
UniProt curated annotations — full annotation on UniProt →
Function. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages.
Subcellular location. Membrane.
Tissue specificity. Expressed preferentially in retina.
Activity regulation. Channel activity is regulated by variations of cytosolic pH; channels are activated by alkaline and inhibited by acidic pH values. Inhibited by Ba(2+) and Cs(+) in a voltage-dependent manner; sensitivity to those inhibitors is lower than in other Kir channels.
Similarity. Belongs to the inward rectifier-type potassium channel (TC 1.A.2.1) family. KCNJ14 subfamily.
RefSeq proteins (1): NP_037480* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013518 | K_chnl_inward-rec_Kir_cyto | Homologous_superfamily |
| IPR014756 | Ig_E-set | Homologous_superfamily |
| IPR016449 | K_chnl_inward-rec_Kir | Family |
| IPR040445 | Kir_TM | Domain |
| IPR041647 | IRK_C | Domain |
Pfam: PF01007, PF17655
Catalyzed reactions (Rhea), 1 shown:
- K(+)(in) = K(+)(out) (RHEA:29463)
UniProt features (15 total): topological domain 4, compositionally biased region 2, transmembrane region 2, region of interest 2, chain 1, short sequence motif 1, modified residue 1, sequence variant 1, intramembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UNX9-F1 | 80.89 | 0.65 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 81
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-1296053 | Classical Kir channels |
| R-HSA-5576886 | Phase 4 - resting membrane potential |
| R-HSA-112316 | Neuronal System |
| R-HSA-1296065 | Inwardly rectifying K+ channels |
| R-HSA-1296071 | Potassium Channels |
| R-HSA-397014 | Muscle contraction |
| R-HSA-5576891 | Cardiac conduction |
MSigDB gene sets: 104 (showing top):
GOBP_POTASSIUM_ION_TRANSPORT, RNGTGGGC_UNKNOWN, REACTOME_POTASSIUM_CHANNELS, REACTOME_INWARDLY_RECTIFYING_K_CHANNELS, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN, GGGTGGRR_PAX4_03, GOBP_MONOATOMIC_CATION_TRANSPORT, BLALOCK_ALZHEIMERS_DISEASE_UP, ZIC1_01, GOBP_IMPORT_INTO_CELL, GOBP_TRANSMEMBRANE_TRANSPORT, TGGAAA_NFAT_Q4_01, LEIN_PONS_MARKERS, LEIN_MEDULLA_MARKERS, GOCC_POTASSIUM_CHANNEL_COMPLEX
GO Biological Process (5): regulation of monoatomic ion transmembrane transport (GO:0034765), potassium ion import across plasma membrane (GO:1990573), monoatomic ion transport (GO:0006811), potassium ion transport (GO:0006813), monoatomic ion transmembrane transport (GO:0034220)
GO Molecular Function (1): inward rectifier potassium channel activity (GO:0005242)
GO Cellular Component (4): plasma membrane (GO:0005886), voltage-gated potassium channel complex (GO:0008076), membrane (GO:0016020), monoatomic ion channel complex (GO:0034702)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Inwardly rectifying K+ channels | 1 |
| Cardiac conduction | 1 |
| Potassium Channels | 1 |
| Neuronal System | 1 |
| Muscle contraction | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| monoatomic ion transmembrane transport | 1 |
| regulation of transmembrane transport | 1 |
| regulation of monoatomic ion transport | 1 |
| potassium ion transmembrane transport | 1 |
| inorganic cation import across plasma membrane | 1 |
| transport | 1 |
| metal ion transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| voltage-gated potassium channel activity | 1 |
| ligand-gated monoatomic cation channel activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| potassium channel complex | 1 |
| plasma membrane protein complex | 1 |
| cellular anatomical structure | 1 |
| transmembrane transporter complex | 1 |
Protein interactions and networks
STRING
576 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KCNJ14 | LRIT2 | A6NDA9 | 518 |
| KCNJ14 | KCNK6 | Q9Y257 | 485 |
| KCNJ14 | TMEM68 | Q96MH6 | 472 |
| KCNJ14 | CCDC126 | Q96EE4 | 466 |
| KCNJ14 | NTN5 | Q8WTR8 | 461 |
| KCNJ14 | WDR17 | Q8IZU2 | 459 |
| KCNJ14 | KCNB2 | Q92953 | 442 |
| KCNJ14 | KCNB1 | Q14721 | 422 |
| KCNJ14 | SCN4A | P35499 | 416 |
| KCNJ14 | HAO1 | Q9UJM8 | 411 |
| KCNJ14 | CACNA1S | Q13698 | 410 |
| KCNJ14 | KCNN2 | Q9H2S1 | 391 |
| KCNJ14 | KCNA7 | Q96RP8 | 388 |
| KCNJ14 | KCND1 | Q9NSA2 | 382 |
| KCNJ14 | KCNC4 | Q03721 | 344 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: B7U540, E1BN00, E1BNE9, F1NHE9, O02822, O18839, O19182, O60928, O70617, P35561, P48050, P48051, P48542, P48543, P48549, P48550, P49656, P49658, P52185, P52186, P52187, P52188, P52189, P52190, P52191, P52192, P63250, P63251, P63252, P63253, P70673, P86046, P97794, Q14500, Q14654, Q15842, Q4TZY1, Q5NVJ6, Q61743, Q63511
Diamond homologs: B7U540, E1BN00, E1BNE9, F1MYR9, F1NHE9, O02670, O02822, O18839, O19182, O60928, O70339, O70596, O70617, O88335, O88932, P35560, P35561, P48048, P48050, P48051, P48542, P48543, P48544, P48545, P48548, P48549, P48550, P49655, P49656, P49658, P52185, P52186, P52187, P52188, P52189, P52190, P52191, P52192, P63250, P63251
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
490 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:48455649:G:GT | donor_gain | 0.9900 |
| 19:48455649:G:T | donor_gain | 0.9900 |
| 19:48464152:T:A | acceptor_gain | 0.9900 |
| 19:48464158:T:A | acceptor_gain | 0.9900 |
| 19:48464159:G:A | acceptor_gain | 0.9900 |
| 19:48465942:G:GT | donor_gain | 0.9900 |
| 19:48465943:A:T | donor_gain | 0.9900 |
| 19:48465953:TGAAG:T | donor_loss | 0.9900 |
| 19:48465956:AG:A | donor_loss | 0.9900 |
| 19:48465957:GG:G | donor_loss | 0.9900 |
| 19:48465958:GTG:G | donor_loss | 0.9900 |
| 19:48464140:T:TA | acceptor_gain | 0.9800 |
| 19:48464149:T:A | acceptor_gain | 0.9800 |
| 19:48464180:GCCCC:G | acceptor_gain | 0.9800 |
| 19:48464080:T:TA | acceptor_gain | 0.9700 |
| 19:48464134:C:A | acceptor_gain | 0.9700 |
| 19:48464142:T:TA | acceptor_gain | 0.9700 |
| 19:48464173:T:A | acceptor_gain | 0.9700 |
| 19:48455629:AAG:A | donor_gain | 0.9600 |
| 19:48464103:A:AG | acceptor_gain | 0.9600 |
| 19:48464104:T:G | acceptor_gain | 0.9600 |
| 19:48464166:C:CA | acceptor_gain | 0.9600 |
| 19:48464176:T:A | acceptor_gain | 0.9600 |
| 19:48464176:TGCA:T | acceptor_loss | 0.9600 |
| 19:48464179:A:AC | acceptor_loss | 0.9600 |
| 19:48464180:G:GC | acceptor_loss | 0.9600 |
| 19:48464180:GC:G | acceptor_gain | 0.9600 |
| 19:48456592:A:G | acceptor_gain | 0.9500 |
| 19:48460820:A:G | acceptor_gain | 0.9500 |
| 19:48464121:C:G | acceptor_gain | 0.9500 |
AlphaMissense
2820 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:48462322:T:C | F200L | 1.000 |
| 19:48462323:T:C | F200S | 1.000 |
| 19:48462324:C:A | F200L | 1.000 |
| 19:48462324:C:G | F200L | 1.000 |
| 19:48462325:A:C | S201R | 1.000 |
| 19:48462326:G:T | S201I | 1.000 |
| 19:48462327:C:A | S201R | 1.000 |
| 19:48462327:C:G | S201R | 1.000 |
| 19:48462373:T:A | W217R | 1.000 |
| 19:48462373:T:C | W217R | 1.000 |
| 19:48462425:C:A | A234D | 1.000 |
| 19:48464278:C:A | P271H | 1.000 |
| 19:48464374:T:C | L303P | 1.000 |
| 19:48464424:T:G | Y320D | 1.000 |
| 19:48464445:T:A | W327R | 1.000 |
| 19:48464445:T:C | W327R | 1.000 |
| 19:48464447:G:C | W327C | 1.000 |
| 19:48464447:G:T | W327C | 1.000 |
| 19:48461893:G:T | G57W | 0.999 |
| 19:48461894:G:A | G57E | 0.999 |
| 19:48461894:G:T | G57V | 0.999 |
| 19:48462317:T:C | L198P | 0.999 |
| 19:48462322:T:A | F200I | 0.999 |
| 19:48462323:T:G | F200C | 0.999 |
| 19:48462326:G:A | S201N | 0.999 |
| 19:48462335:C:A | A204D | 0.999 |
| 19:48462338:T:A | V205D | 0.999 |
| 19:48462343:G:C | A207P | 0.999 |
| 19:48462368:T:C | L215P | 0.999 |
| 19:48462376:C:A | R218S | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000055611 (19:48456853 A>G,T), RS1000126016 (19:48454942 ATTTCT>A), RS1000128892 (19:48458300 C>A,T), RS1000178712 (19:48455144 A>G,T), RS1000430115 (19:48457139 G>C), RS1000511465 (19:48454071 C>A,T), RS1001357501 (19:48464019 C>T), RS1001416266 (19:48462481 G>A,T), RS1002235592 (19:48456491 G>A), RS1002633823 (19:48461396 G>A), RS1002739895 (19:48456628 G>A), RS1002789952 (19:48466828 G>A), RS1003034342 (19:48462658 C>T), RS1003086708 (19:48462451 G>A,C), RS1003093799 (19:48467148 A>C)
Disease associations
OMIM: gene MIM:603953 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: vgic — Inwardly rectifying potassium channels (KIR)
Most potent curated ligand interactions (3 total), top 3:
| Ligand | Action | Affinity | Parameter |
|---|---|---|---|
| H+ | Antagonist | 7.14 | pKi |
| Cs+ | Antagonist | 4.08 | pKd |
| Ba2+ | Antagonist | 3.32 | pKd |
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation | 2 |
| Potassium | decreases reaction, increases transport | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| sulforaphane | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | decreases expression | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | increases methylation | 1 |
| Barium | decreases reaction, increases transport | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Drugs, Chinese Herbal | increases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Naphthoquinones | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Quercetin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Asbestos, Crocidolite | affects methylation | 1 |
| Copper Sulfate | increases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_YA64 | IDG-HEK293T-KCNJ14-V5-OE | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.